GI Innovation allergic diseases treatment
Scope
Date
~
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Artificial intelligence
S.Korea’s KT to innovate media, content businesses with AI
South Korea’s telecom giant KT Corp. is set to innovate its media and content businesses with artificial intelligence as it seeks new growth d...
Apr 29, 2024 (Gmt+09:00)
-
Korean startups
Bet on innovations with societal impact: Kakao Ventures CEO
In the past 10 years, Kim Ki-jun has been on the hunt for deep technology startups that will have a significant societal impact, and he will continu...
Apr 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Future mobility
Hyundai, Toray to team up to develop mobility materials
Hyundai Motor Group said on Thursday it has signed a strategic partnership agreement with Japan's Toray Industries Inc. to jointly develop carbon fi...
Apr 18, 2024 (Gmt+09:00)
-
Corporate strategy
SK Innovation to adjust business portfolios for long-term growth
SK Innovation Co., South Korea’s top energy company, is slated to adjust its business portfolios for long-term growth while not planning to sl...
Apr 17, 2024 (Gmt+09:00)
-
Artificial intelligence
Lotte Innovate, Kolon Benit to cooperate on AI Solutions
South Korea’s Lotte Innovate (formerly, Lotte Data Communication Co. ) announced that it signed a memorandum of understanding (MOU) with Kolon...
Apr 15, 2024 (Gmt+09:00)
-
Corporate strategy
SK Innovation reshuffles units to raise value
SK Innovation Co., South Korea’s top energy company, is reorganizing its subsidiaries to boost their individual values through independent man...
Apr 11, 2024 (Gmt+09:00)
-
Fashion
LF’s fashion brand Dunst teams up with E-Land for China push
South Korean clothing company LF Corp. said on Monday that its street fashion brand Dunst will build an offline presence in China in partnership wit...
Apr 01, 2024 (Gmt+09:00)
-
Batteries
POSCO Future M named Fortune Asia Future 30
South Korea’s POSCO Future M Co. has been named Asia Future 30 by the US economic media Fortune on Mar. 27, according to the company on Thursd...
Mar 28, 2024 (Gmt+09:00)
-
Batteries
Ferrari, SK On team up to innovate battery technology
Ferrari S.p.A. joined hands with SK On Co., the world’s fifth-largest electric vehicle battery producer, to innovate cell technology as the It...
Mar 27, 2024 (Gmt+09:00)
-
Bio & Pharma
Genesystem enters Indian tuberculosis treatment market
Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kit...
Mar 27, 2024 (Gmt+09:00)
-
Korean startups
Asan Nanum Foundation invites innovators to startup pitch
The Asan Nanum Foundation, a nonprofit foundation set up in 2011 to commemorate the 10th anniversary of Hyundai founder Chung Ju-yung’s death,...
Mar 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Mar 24, 2024 (Gmt+09:00)
-
Artificial intelligence
Naver, named 3rd most innovative company in the Asia-Pacific
South Korea’s online giant Naver Corp. ranked as the third most innovative company in the Asia-Pacific by a top US business magazine for the p...
Mar 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Reversing age possible in a decade: Harvard Prof. David Sinclair
Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...
Mar 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Vivid Health gets seed round from Kakao Ventures
Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...
Mar 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...
Feb 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis to supply Hadlima to US government
South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and developmen...
Feb 21, 2024 (Gmt+09:00)
-
Artificial intelligence
Kakao Brain releases medical GenAI tech for free
Kakao Brain, an artificial intelligence (AI) R&D subsidiary of South Korea's Kakao Corp., announced on Tuesday that it has uploaded the Labeler ...
Feb 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Korean Investors
Samsung Asset to launch S.Korea's first obesity treatment ETF
Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Kakao launches AI-based blood sugar management solution
South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digi...
Feb 01, 2024 (Gmt+09:00)
-
Artificial intelligence
LG CNS launches AI center for synergy of business, research
South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., said on Sunday it has launched an artificial intelligence center to stre...
Jan 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)